Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 22,648 | 8,985 | 6,978 | 31,281 | 6,218 |
| Gross Profit | 22,648 | 8,985 | 6,978 | 31,281 | 6,218 |
| Operating Expenses | 80,057 | 72,497 | 63,448 | 54,875 | 47,115 |
| Operating Income | -57,409 | -63,512 | -56,470 | -23,594 | -40,897 |
| Other Income | 923 | 678 | 517 | 396 | 276 |
| Pre-tax Income | -56,486 | -62,834 | -55,953 | -23,198 | -40,621 |
| Net Income Continuous | -56,486 | -62,834 | -55,953 | -23,198 | -40,621 |
| Net Income | $-56,486 | $-62,834 | $-55,953 | $-23,198 | $-40,621 |
| EPS Basic Total Ops | -1.36 | -1.63 | -1.47 | -0.61 | -1.10 |
| EPS Basic Continuous Ops | -1.36 | -1.63 | -1.47 | -0.61 | -1.08 |
| EPS Diluted Total Ops | -1.36 | -1.63 | -1.47 | -0.61 | -1.10 |
| EPS Diluted Continuous Ops | -1.36 | -1.63 | -1.47 | -0.61 | -1.08 |
| EBITDA(a) | $-55,448 | $-61,872 | $-54,962 | $-22,222 | $-39,644 |